US20100140185A1 - Wastewater treatment - Google Patents
Wastewater treatment Download PDFInfo
- Publication number
- US20100140185A1 US20100140185A1 US12/592,699 US59269909A US2010140185A1 US 20100140185 A1 US20100140185 A1 US 20100140185A1 US 59269909 A US59269909 A US 59269909A US 2010140185 A1 US2010140185 A1 US 2010140185A1
- Authority
- US
- United States
- Prior art keywords
- wastewater
- biocidal
- silver
- compound containing
- hydantoin ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004065 wastewater treatment Methods 0.000 title description 7
- 239000002351 wastewater Substances 0.000 claims abstract description 148
- 230000003115 biocidal effect Effects 0.000 claims abstract description 65
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical group O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 claims abstract description 61
- 150000001875 compounds Chemical class 0.000 claims abstract description 54
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 28
- 244000005700 microbiome Species 0.000 claims abstract description 25
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 22
- 239000007787 solid Substances 0.000 claims abstract description 14
- 239000004599 antimicrobial Substances 0.000 claims abstract description 13
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 4
- 229910052709 silver Inorganic materials 0.000 claims description 76
- 239000004332 silver Substances 0.000 claims description 76
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 47
- -1 transition metal salt Chemical class 0.000 claims description 38
- YIROYDNZEPTFOL-UHFFFAOYSA-N 5,5-Dimethylhydantoin Chemical compound CC1(C)NC(=O)NC1=O YIROYDNZEPTFOL-UHFFFAOYSA-N 0.000 claims description 30
- 229910052751 metal Inorganic materials 0.000 claims description 26
- 239000002184 metal Substances 0.000 claims description 26
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 11
- PQRDTUFVDILINV-UHFFFAOYSA-N bcdmh Chemical compound CC1(C)N(Cl)C(=O)N(Br)C1=O PQRDTUFVDILINV-UHFFFAOYSA-N 0.000 claims description 10
- 239000003344 environmental pollutant Substances 0.000 claims description 10
- 231100000719 pollutant Toxicity 0.000 claims description 10
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims description 10
- 229910021607 Silver chloride Inorganic materials 0.000 claims description 9
- 229910052723 transition metal Inorganic materials 0.000 claims description 9
- 229910001316 Ag alloy Inorganic materials 0.000 claims description 8
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 claims description 8
- 150000002739 metals Chemical class 0.000 claims description 7
- VRLDVERQJMEPIF-UHFFFAOYSA-N dbdmh Chemical compound CC1(C)N(Br)C(=O)N(Br)C1=O VRLDVERQJMEPIF-UHFFFAOYSA-N 0.000 claims description 6
- 229940091173 hydantoin Drugs 0.000 claims description 6
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- 239000010797 grey water Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 4
- 229910001923 silver oxide Inorganic materials 0.000 claims description 4
- 229910000314 transition metal oxide Inorganic materials 0.000 claims description 4
- 150000003624 transition metals Chemical class 0.000 claims description 4
- RHYBFKMFHLPQPH-UHFFFAOYSA-N N-methylhydantoin Chemical compound CN1CC(=O)NC1=O RHYBFKMFHLPQPH-UHFFFAOYSA-N 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 230000000153 supplemental effect Effects 0.000 abstract description 3
- 239000003139 biocide Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 19
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 12
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- JROGBPMEKVAPEH-GXGBFOEMSA-N emetine dihydrochloride Chemical compound Cl.Cl.N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC JROGBPMEKVAPEH-GXGBFOEMSA-N 0.000 description 7
- 229910017611 Ag(NH3)2 Inorganic materials 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 229910001385 heavy metal Inorganic materials 0.000 description 4
- 150000001469 hydantoins Chemical class 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000010866 blackwater Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical class [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 3
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 2
- DQQLZADYSWBCOX-UHFFFAOYSA-N 2-(2,5-dioxoimidazolidin-4-yl)acetic acid Chemical compound OC(=O)CC1NC(=O)NC1=O DQQLZADYSWBCOX-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940125833 compound 23 Drugs 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 239000010794 food waste Substances 0.000 description 2
- 239000010800 human waste Substances 0.000 description 2
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 description 2
- 239000010842 industrial wastewater Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- WEOHANUVLKERQI-UHFFFAOYSA-N (2,4-dioxoimidazolidin-1-yl)azanium;chloride Chemical compound Cl.NN1CC(=O)NC1=O WEOHANUVLKERQI-UHFFFAOYSA-N 0.000 description 1
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 1
- MMGJNINGVUMRFI-UHFFFAOYSA-N 15686-38-1 Chemical compound C1CC2(C3=C(C4=CC=CC=C4N3)C3)CCCCC2C3N1CC1CC1 MMGJNINGVUMRFI-UHFFFAOYSA-N 0.000 description 1
- KZKRPYCBSZIQKN-UHFFFAOYSA-N 2-Imidazolidone-4-carboxylic acid Chemical compound OC(=O)C1CNC(=O)N1 KZKRPYCBSZIQKN-UHFFFAOYSA-N 0.000 description 1
- VWSLLSXLURJCDF-UHFFFAOYSA-N 2-methyl-4,5-dihydro-1h-imidazole Chemical compound CC1=NCCN1 VWSLLSXLURJCDF-UHFFFAOYSA-N 0.000 description 1
- NXJZQSRAFBHNLI-UHFFFAOYSA-N 2-oxoimidazolidine-1-carbonyl chloride Chemical compound ClC(=O)N1CCNC1=O NXJZQSRAFBHNLI-UHFFFAOYSA-N 0.000 description 1
- BKCCAYLNRIRKDJ-UHFFFAOYSA-N 2-phenyl-4,5-dihydro-1h-imidazole Chemical compound N1CCN=C1C1=CC=CC=C1 BKCCAYLNRIRKDJ-UHFFFAOYSA-N 0.000 description 1
- UGWULZWUXSCWPX-UHFFFAOYSA-N 2-sulfanylideneimidazolidin-4-one Chemical compound O=C1CNC(=S)N1 UGWULZWUXSCWPX-UHFFFAOYSA-N 0.000 description 1
- HSJPRHDSBNINIJ-UHFFFAOYSA-N 4-(4,5-dihydro-1h-imidazol-2-yl)aniline Chemical compound C1=CC(N)=CC=C1C1=NCCN1 HSJPRHDSBNINIJ-UHFFFAOYSA-N 0.000 description 1
- VSJRBQDMBFFHMC-UHFFFAOYSA-N 5-ethyl-5-methylimidazolidine-2,4-dione Chemical compound CCC1(C)NC(=O)NC1=O VSJRBQDMBFFHMC-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- PDQAZBWRQCGBEV-UHFFFAOYSA-N Ethylenethiourea Chemical compound S=C1NCCN1 PDQAZBWRQCGBEV-UHFFFAOYSA-N 0.000 description 1
- DJDFFEBSKJCGHC-UHFFFAOYSA-N Naphazoline Chemical compound Cl.C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 DJDFFEBSKJCGHC-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229910021612 Silver iodide Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229910052946 acanthite Inorganic materials 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002353 algacidal effect Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001450 anions Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000001479 atomic absorption spectroscopy Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- WIKQEUJFZPCFNJ-UHFFFAOYSA-N carbonic acid;silver Chemical compound [Ag].[Ag].OC(O)=O WIKQEUJFZPCFNJ-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 150000002461 imidazolidines Chemical class 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- SQUAOXHPCJIDJM-UHFFFAOYSA-N methyl 4-(2-methoxyphenyl)-4-oxobutanoate Chemical compound COC(=O)CCC(=O)C1=CC=CC=C1OC SQUAOXHPCJIDJM-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940045641 monobasic sodium phosphate Drugs 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229960004186 naphazoline nitrate Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- ZFLIKDUSUDBGCD-UHFFFAOYSA-N parabanic acid Chemical compound O=C1NC(=O)C(=O)N1 ZFLIKDUSUDBGCD-UHFFFAOYSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- 229940100890 silver compound Drugs 0.000 description 1
- 150000003379 silver compounds Chemical class 0.000 description 1
- 229910000161 silver phosphate Inorganic materials 0.000 description 1
- 229910000367 silver sulfate Inorganic materials 0.000 description 1
- KQTXIZHBFFWWFW-UHFFFAOYSA-L silver(I) carbonate Inorganic materials [Ag]OC(=O)O[Ag] KQTXIZHBFFWWFW-UHFFFAOYSA-L 0.000 description 1
- 229910000108 silver(I,III) oxide Inorganic materials 0.000 description 1
- JIKVETCBELSHNU-UHFFFAOYSA-M silver;3-oxobutanoate Chemical compound [Ag+].CC(=O)CC([O-])=O JIKVETCBELSHNU-UHFFFAOYSA-M 0.000 description 1
- CLDWGXZGFUNWKB-UHFFFAOYSA-M silver;benzoate Chemical compound [Ag+].[O-]C(=O)C1=CC=CC=C1 CLDWGXZGFUNWKB-UHFFFAOYSA-M 0.000 description 1
- FSJWWSXPIWGYKC-UHFFFAOYSA-M silver;silver;sulfanide Chemical compound [SH-].[Ag].[Ag+] FSJWWSXPIWGYKC-UHFFFAOYSA-M 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- JIVZKJJQOZQXQB-UHFFFAOYSA-N tolazoline Chemical compound C=1C=CC=CC=1CC1=NCCN1 JIVZKJJQOZQXQB-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000003253 viricidal effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/50—Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment
- C02F1/505—Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment by oligodynamic treatment
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F21/00—Dissolving
- B01F21/20—Dissolving using flow mixing
- B01F21/22—Dissolving using flow mixing using additional holders in conduits, containers or pools for keeping the solid material in place, e.g. supports or receptacles
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
- C02F1/685—Devices for dosing the additives
- C02F1/688—Devices in which the water progressively dissolves a solid compound
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/72—Treatment of water, waste water, or sewage by oxidation
- C02F1/76—Treatment of water, waste water, or sewage by oxidation with halogens or compounds of halogens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1404—Handling flow, e.g. hydrodynamic focusing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1484—Optical investigation techniques, e.g. flow cytometry microstructural devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F21/00—Dissolving
- B01F21/40—Dissolving characterised by the state of the material being dissolved
- B01F21/402—Dissolving characterised by the state of the material being dissolved characterised by the configuration, form or shape of the solid material, e.g. in the form of tablets or blocks
- B01F21/4021—Dissolving characterised by the state of the material being dissolved characterised by the configuration, form or shape of the solid material, e.g. in the form of tablets or blocks in the form of tablets stored in containers, canisters or receptacles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0636—Focussing flows, e.g. to laminate flows
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0654—Lenses; Optical fibres
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0433—Moving fluids with specific forces or mechanical means specific forces vibrational forces
- B01L2400/0436—Moving fluids with specific forces or mechanical means specific forces vibrational forces acoustic forces, e.g. surface acoustic waves [SAW]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/002—Grey water, e.g. from clothes washers, showers or dishwashers
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/008—Originating from marine vessels, ships and boats, e.g. bilge water or ballast water
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2201/00—Apparatus for treatment of water, waste water or sewage
- C02F2201/002—Construction details of the apparatus
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2303/00—Specific treatment goals
- C02F2303/04—Disinfection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/02—Separating microorganisms from the culture medium; Concentration of biomass
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/149—Optical investigation techniques, e.g. flow cytometry specially adapted for sorting particles, e.g. by their size or optical properties
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1404—Handling flow, e.g. hydrodynamic focusing
- G01N2015/142—Acoustic or ultrasonic focussing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1486—Counting the particles
Definitions
- This invention relates generally to wastewater treatment and, more specifically to treatment of wastewater to kill microorganisms therein.
- Wastewater which may be either residential or industrial wastewater, may be in various conditions and may include human waste, food scraps, oil, soaps and chemical. Household wastewater generally comes from household appliances, bathtubs, showers and toilets. Wastewater that is heavily polluted is often referred to as black water and household wastewater that does not include toilet waste is often referred to as greywater since, although polluted, it generally contains lesser amounts of pollutants.
- biocidal metals are effective in killing microorganisms
- one of the difficulties with killing microorganisms in wastewater with biocidal metals is that in the presence of wastewater the solubility of the biocidal metal ions may not be sufficiently high so as to effectively kill the microorganism in the wastewater.
- wastewater is found in industrial applications and industrial facilities where wastewater is used for a variety of tasks including cooling, cooking, manufacturing and other process that require the use of water that results in contamination of the water and requires that the wastewater be subject to an antimicrobial treatment before retuning the water to the environment.
- Still other types of wastewater include water, which is used in the hold of ships for ballast. Conditions within the water storage can not only pollute the water with solids but also can cause growth of harmful microorganisms as well as transfer of harmful microorganisms from one geographical location to another geographical location as a ship picks up ballast water in one port and discharges the ballast at another port or at sea. Before the wastewater is discharged back into the sea or a reservoir the harmful microorganisms in the water, which is used as ballast, needs to be subjected to an antimicrobial treatment to kill the harmful microorganisms before the water is discharged.
- the present invention comprises a method of killing microorganisms in wastewater with biocidal metal ions by elevating the concentration of available biocidal metal ions in the wastewater addition by including of an additive to the wastewater, which may or may not have any antimicrobial properties.
- the invention includes a dispenser with an antimicrobial agent comprising a compound containing a hydantoin ring and a biocidal metal ion source
- the invention includes method of killing microbes in wastewater by adding a source of biocidal metal ions to the body of wastewater together with a compound containing a hydantoin ring to enhance the biocidal metal ion concentration to a level effective to kill the microorganisms in the wastewater.
- the compound containing a hydantoin ring may be tabletized, or be in liquid, powder or other solid form so the compound containing the hydantoin ring can be placed in a body of wastewater together with a source of biocidal metal ions to kill microorganisms the wastewater.
- FIG. 1 discloses a system for treating wastewater
- FIG. 2 shows the concentrations of silver with and without the addition of DMH
- FIG. 3 shows an example of a one-chamber dispenser
- FIG. 4 shows an example of a two-chamber dispenser
- FIG. 5 shows a schematic of a hydantoin ring.
- FIG. 1 discloses a wastewater treatment system 10 for recycling wastewater to a state where the water is either fit for human consumption, agricultural use or otherwise returned to the environment.
- Wastewater of all types which includes but is not limited to residential wastewater, industrial wastewater, commercial wastewater and reservoir wastewater comes in various conditions and may include human waste, food scraps, oil, soaps and chemical.
- Household wastewater generally comes from household appliances, bathtubs, showers and toilets. Wastewater that is heavily polluted is often referred to as black water and household wastewater that does not include toilet waste is often referred to as greywater since, although polluted, it generally contains lesser amounts of pollutants.
- Wastewater treatment system 10 includes a holding tank 11 that receives wastewater from an inlet pipe 12 ,
- the wastewater can be from commercial, industrial or households septic systems and can be either greywater or blackwater.
- the wastewater is pumped to a water treatment station 12 where solid or particle pollutants are removed from the wastewater. Solids may be removed through various methods including centrifuges or gravitation settling. The solid pollutants are removed through outlet 12 a and the wastewater with the solid pollutants removed is then pumped through pipe 15 to another water treatment station 14 where unwanted liquids such as oils or soaps are removed from the wastewater and discharged through outlet 14 a . Smaller particles or unwanted liquids may be removed by filters or the like. Once the unwanted liquids are removed from the wastewater the wastewater is pumped to water purification station 16 through pipe 17 .
- the amount and type of treatment of the wastewater in purification chamber 16 depends on the eventual use of water in purification chamber 16 .
- the unwanted organisms in the wastewater need to be killed to render the water suitable for human consumption.
- One of the effective ways of killing harmful organisms, such as bacteria, in wastewater is the use of biocidal metals that release heavy metals ions and particularly heavy metals ions such as silver ions.
- biocidal metals that release heavy metals ions and particularly heavy metals ions such as silver ions.
- silver ions are effective in killing harmful unwanted organisms the solubility of silver ions in water is limited and hence the effectiveness in quickly and effectively killing harmful bacterial is also limited.
- wastewater treatment involves the removal of pollutants in the wastewater
- the type of wastewater treatment required will depend on the type of wastewater being processed as well as the final use for the wastewater.
- one of the final processing steps includes the killing of harmful organism in the wastewater.
- wastewater is purified either partly or wholly through the use of a heavy metal ion donor that releases heavy metal ions such as silver ions.
- silver ions are effective in killing harmful organisms the low solubility of the silver ions in water limits the effectiveness of the silver ions to provide an effective and quick kill of harmful organisms in the wastewater.
- the effectiveness of the metal ions, particularly the silver ions is enhanced through increasing the solubility of the silver ions by addition of a compound containing a hydantoin ring.
- FIG. 5 shows a schematic of the structure of a hydantoin ring with carbon and nitrogen atoms joined in a five-sided ring.
- An oxygen atom is attached to two of the carbons in the hydantoin ring.
- the lines extending from the third carbon atom and the nitrogen atom indicate that other atoms could be attached thereto.
- a compound containing a hydantoin ring such as DMH (5,5-dimethylhydantoin)
- two methyl groups would be attached to the carbon atom
- an a hydrogen atom would be attached to each of the two nitrogen atoms.
- halogenated hydantoins such as Bromochlorodimethylhydantoin (BCDMH) and Dibromodimethylhydantoin (DBDMH) when combined with a metal ion donor may be used in pools and spas to kill microorganisms (U.S. Pat. No. 7,347,934),
- a compound containing a hydantoin ring such as 5,5-dimethylhydantoin (DMH), which lacks antimicrobial properties, has the ability to interact with a source of metal ions to increase the solubility of the silver in wastewater to increase the effectiveness of the antimicrobial process in the wastewater.
- DMH 5,5-dimethylhydantoin
- Examples of other well known compounds wherein the compound contains a hydantoin ring include 1-hydroxymethyl-5,5-dimethlyl hydantoin, glycolyurea and Copper hydantoin, Hydantoin-5-acetic acid, and Imidazolidines including parabanic acid, 2-Thiohydantoin, hydantoin purum, hydantoin, 1-Aminohydantoin hydrochloride, 2-Imidazolidone, 2-Imidazolidone purum, 2-Imidazolidinethione, 2-hydrazino-2-imidazoline hydrobromide, 2-oxo-1-imidazolidinecarbonyl chloride, 1-methyl hydantoin, 5-methylhydandtoin, 2-imidazolidone-4-carboxylic acid, allantoin, allantoin purum, creatinine anhydrous, creatinine biochemika, creatinine hydrochloride, 2-methyl-2-imidazoline, 2-methylithi
- a test was performed using either silver chloride or silver bromide as the donor of silver metal ions. The test demonstrated the enhancement of the silver ion concentration in a water environment when DMH is used in combination with the source of silver ions even though the DMH lacked any independent antimicrobial properties.
- Silver bromide was initially prepared from a saturated sodium bromide solution, combined with silver nitrate in solution. The yellow precipitate, silver bromide, was than purified by filtration and washing. Additionally, the solid was allowed to dry before use.
- a buffer system having a pH of 7.41 was prepared by adding Fisherbrand® potassium phosphate monobasic-sodium phosphate dibasic buffer to 2 Erlenmeyer flasks filled with 1000 mL of purified water. The first flask was treated with 1.12 grams of 5,5-dimethylhydantoin (DMH) and marked solution “C” (with DMH) and the second flask was left untreated and marked solution “D” (without DMH) for control.
- DMH 5,5-dimethylhydantoin
- the 5,5-dimethylhydantoin (DMH) comprised 97% reagent grade was obtained from Aldrich® (CAS No. 77-71-4, Cat. No. D161403-1KG).
- FIG. 2 shows a table containing a list of the dissolved silver concentration, in parts per billion (ppb) obtained from the 100 ml samples for solution “D” (without DMH) and solution “C” (with DMH) at each of their respective weekly time intervals.
- the average concentration of dissolved silver for solution “C” (with DMH) was 86 ppb while solution “D” (without DMH) had an average concentration of dissolved silver of 4.7 ppb.
- the King Technology, Inc. Frog® Mineral Cartridge is known to provide silver ions in the form of solid silver chloride (AgCl) distributed over a porous matrix. Water flowing through the matrix comes into contact with the AgCl resulting in the release of soluble silver ions to water. DMH was also released into the water resulting in the formation of ionic-hydantoin structures. It would be anticipated that soluble silver ions would be depleted from water through the formation of silver bromide, an insoluble salt. However, as shown in FIG. 2 after the DMH was added to the water, the actual silver concentrations were higher than the calculated theoretical silver concentration.
- FIG. 3 shows a dispenser 20 having a housing 21 containing a compartment 22 therein for the compound containing the hydantoin ring and a source of biocidal metal ions such as silver ions.
- a compound 23 Located in compartment 22 is a compound 23 containing a hydantoin ring such as DMH and a biocidal component such a biocidal metal for generating biocidal metal ions into a body of wastewater.
- a biocidal metal such as zinc or copper may be use
- the preferred biocidal metals comprise silver, silver alloy or some combination thereof, because of the recognized bactericidal, viricidal, and algaecidal properties of silver.
- the biocidal metals can be introduced as metallic, zero valence material, or as metal ions that can be introduced into the water by dissolution of soluble metal salts, or by the dissolution of the metal itself.
- silver ion can be introduced into the water through the dissolution of silver nitrate, or through the dissolution of metallic silver as the result of conversion to silver oxide and subsequent conversion of the oxide to more soluble silver species.
- Mixtures of different salts, or of salts with metallic material may be combined together to provide the necessary concentration of metal ions in the water.
- the biocidal metal is in a dry or inactive state and comprises either metallic silver or a source of silver ions, such as silver chloride 24 .
- the compound containing the hydantoin ring is also in a dry or inactive state, with both compound containing the hydantoin ring and the silver chloride entering into an active state in the presence of wastewater.
- a set of openings 25 allows water access to compartment 22 and to the source of the compound containing a hydantoin ring 23 and the source of silver ions 24 .
- insoluble or slightly soluble transition metal salts may also be used in the present invention as a source of silver ions.
- examples of insoluble or slightly soluble transition metal salts suitable for use in the present invention include, but are not limited to, AgCl, AgBr, AgI, Ag 2 S, Ag 3 PO 4 , NaAg 2 PO 4 , CuS, and NaCuPO 4 .
- silver compounds include, but are not limited to, AgNO 3 , Ag 2 CO 3 , AgOAc, Ag 2 SO 4 , Ag 2 O, [Ag(NH 3 ) 2 ]Cl, [Ag(NH 3 ) 2 ]Br, [Ag(NH 3 ) 2 ]I, [Ag(NH 3 ) 2 ]NO 3 , [Ag(NH 3 ) 2 ] 2 SO 4 , silver acetoacetate a silver benzoate, a silver carboxylate, silver amine complexes such as [Ag(NR 3 ) 2 ]X, where R is an alkyl or aryl group or substituted alkyl or aryl group and X is an anion such as, but not limited to, Cl ⁇ , Br ⁇ , I ⁇ , OAc ⁇ , NO 3 ⁇ and SO 4 2 ⁇ .
- FIG. 4 shows a further example of wasterwater treating system including a dispenser 26 having a first housing 27 containing a compartment 28 and a second housing 29 with a compartment 30 therein.
- a silver ion donor such as metallic silver 31
- a source of compound 32 containing a hydantoin ring such as DMH.
- a set of openings 33 allows water access to compartment 28 and to the metallic silver 31 .
- a set of openings 34 allows water access to compartment 30 and the source of DMH.
- the silver ion donor such as silver, silver oxide, silver salt, or a combination thereof
- various types of silver alloys may also be used.
- the silver may be used standing along in its pure/elemental or alloyed form or coated or impregnated to a substrate and placed in compartment 28 .
- other types of silver ion donors, other types of transition metal, a transition metal oxide, or a combination thereof, and other alternative bactericides whose solubility can be changed in the presence of DMH can also be used in the present invention.
- FIG. 3 shows source of compound containing a hydantoin ring 22 in particle form with the aforementioned particles having an initial size that is larger than the size of opening 23 to prevent the particles from escaping through opening 23 .
- FIG. 3 shows source of compound containing a hydantoin ring 23 in tablet form.
- MCC microcrystalline cellulose
- santizing tablets which are tabletized with a metal ion donor so that both the compound containing a hydantoin ring and the metal ion donor can be placed in the body of fluid to be treated.
- the preferred level of the compound containing a hydantoin ring in his case which is DMH is present in the body of wastewater is between 5 and 25 ppm with the DMH and the source of silver cooperating to maintain a level of silver ions present in the amount of 1 to 3 ppb and/or alternatively cooperating to maintain a level of silver ions present to sustain a standard plate count at 35 degrees F. of less than 200 colonies per milliliter.
- the invention includes an antimicrobial agent for killing microorganisms in a body of wastewater
- the antimicrobial agent includes a source of biocidal metal ions releasable into the body of wastewater to generate an antimicrobial level of biocidal metals that may be insufficient to kill the microorganisms in the body of wastewater and a compound containing a hydantoin ring releasable into the body of wastewater wherein the compound containing the hydantoin ring increases the antimicrobial level of biocidal metal ions in the body of wastewater to a biocidal level sufficient to kill microorganism in the wastewater.
- the invention also includes the step of placing the dispenser 20 , 26 containing both the source of compound 23 containing a hydantoin ring, and the source of silver ions 24 , 31 in the body of wastewater and allowing water to come into contact with the DMH 33 , 32 and the source of silver ion 24 , 31 to periodically release DMH and silver ions into the body of wastewater.
- the DMH As the DMH is released into the body of wastewater, the DMH is carried to the source of silver ions 24 , 31 and interacts with the source of silver 24 , 31 to increase the solubility of the silver ions to allow for the release of more silver ions into the body of wastewater than if the source of silver ions 24 , 31 alone thereby increasing the level of silver ions to a level sufficient to kill the microorganisms in the wasterwater.
- the invention also include a method of treating a body of wastewater to kill microorganisms by enhancing the microbial agents comprising the steps of (1) adding a biocidal component 14 , 21 to the body of wastewater; and (2) adding a concentration of compound containing a hydantoin ring such as 5,5-dimethylhydantoin 13 , 22 to the body of wastewater to enhance the effectiveness of the biocidal component 14 , 21 in the body of wastewater to thereby lessen the need for a supplemental biocide.
- the aforementioned method can also include the steps of (3) adding a transition metal, a transition metal oxide, a transition metal salt, or a combination thereof to the body of wastewater; (4) adding silver, silver oxide, silver salt, or a combination thereof to the body of wastewater; (5) adding a substrate that has been coated or impregnated with metallic silver, silver salt, or a combination thereof to the body of wastewater; (6) a silver alloy to the body of wastewater; (7) adding silver nitrate to the body of wastewater; (8) adding a carrier containing a silver deposit to the body of wastewater; (9) adding a silver-containing material to the body of wastewater; (10) placing a dispenser 10 , 16 containing both the biocidal component 14 , 21 and the 5,5-dimethylhydantoin 13 , 22 in the body of wastewater and allowing water to come into contact with both the biocidal component 14 , 21 and the 5,5-dimethylhydantoin 13 , 22 ; (11) adding an amount of 5,5-dimethylhydantoin
- the invention further includes a method of treating a body of wastewater to kill microorganisms by increasing the effectiveness of an antimicrobial agents comprising the steps of: (1) adding a source of biocidal metal 14 , 21 to the body of wastewater to generate biocidal metal ions in the body of wastewater; and (2) adding compound containing a hydantoin ring such as 5,5-dimethylhydantoin 13 , 22 to the body of wastewater to interact with the biocidal metal 14 , 21 to enhance the biocidal metal ion concentration in the body of wastewater.
- a source of biocidal metal 14 , 21 to the body of wastewater to generate biocidal metal ions in the body of wastewater
- compound containing a hydantoin ring such as 5,5-dimethylhydantoin 13 , 22
- the aforementioned method can also include the steps of (3) adding a source of metallic silver to the body of wastewater; (4) adding metallic silver alloy 14 , 21 to the body of wastewater; (5) placing a dispenser 10 , 16 containing both the source of biocidal metal 14 , 21 and the compound containing a hydantoin ring such as 5,5-dimethylhydantoin 13 , 22 in the body of wastewater and allowing water to come into contact with both the source of biocidal metal 14 , 21 and the 5,5-dimethylhydantoin 13 , 22 ; (6) adding a metallic silver coated or impregnated substrate 14 , 21 to the body of wastewater; and adding a source of pure silver 14 , 21 to the body of wastewater.
- a wastewater antimicrobial agent may include a biocidal metal selected from the group consisting of silver chloride, a metallic silver alloy, pure silver or a substrate impregnated with metallic silver and the compound containing the hydantoin ring where the compound containing the hydantoin ring may be either a non-halogenated hydantoin such as 5,5-dimethylhydantoin (DMH) or a halogenated hydantoin including Bromochlorodimethylhydantoin (BCDMH) or Dichlorodimethylhydatoin (DCDMH) or combinations thereof and the compound containing the hydantoin ring is in either a liquid state or a dry state including, powder, solid, granules, pellets or combinations thereof.
- a biocidal metal selected from the group consisting of silver chloride, a metallic silver alloy, pure silver or a substrate impregnated with metallic silver and the compound containing the hydantoin
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Hydrology & Water Resources (AREA)
- Organic Chemistry (AREA)
- Water Supply & Treatment (AREA)
- Environmental & Geological Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Clinical Laboratory Science (AREA)
- Pest Control & Pesticides (AREA)
- Environmental Sciences (AREA)
- Fluid Mechanics (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Agronomy & Crop Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micromachines (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
An antimicrobial method of treating wastewater and a wastewater antimicrobial dispenser containing an antimicrobial agent for treating a body of wastewater to kill microorganisms by increasing the concentration metal ions therein. The antimicrobial method includes the step of increasing the effectiveness of the biocidal component in the body of wastewater to thereby lessen the need for a supplemental biocide by adding a compound containing a hydantoin ring where the compound containing a hydantoin ring may or may not have any antimicrobial properties. The antimicrobial agent including a source of biocidal metal ions and a compound containing a hydantoin ring where the antimicrobial agent may be a powder, a liquid a solid or combinations thereof.
Description
- This application claims priority from U.S. provisional application 61/200,958 filed Dec. 12, 2008 titled Treatment of Wastewater.
- This invention relates generally to wastewater treatment and, more specifically to treatment of wastewater to kill microorganisms therein.
- An increase in the consumption of water for all types of uses as well as the quest for a cleaner environment generates a need to recycle all types of water including wastewater. Wastewater, which may be either residential or industrial wastewater, may be in various conditions and may include human waste, food scraps, oil, soaps and chemical. Household wastewater generally comes from household appliances, bathtubs, showers and toilets. Wastewater that is heavily polluted is often referred to as black water and household wastewater that does not include toilet waste is often referred to as greywater since, although polluted, it generally contains lesser amounts of pollutants. An example of a system for wastewater separation and wastewater treatment in shown in U.S. Pat. No. 6,299,775. While biocidal metals are effective in killing microorganisms one of the difficulties with killing microorganisms in wastewater with biocidal metals is that in the presence of wastewater the solubility of the biocidal metal ions may not be sufficiently high so as to effectively kill the microorganism in the wastewater.
- Another type of wastewater is found in industrial applications and industrial facilities where wastewater is used for a variety of tasks including cooling, cooking, manufacturing and other process that require the use of water that results in contamination of the water and requires that the wastewater be subject to an antimicrobial treatment before retuning the water to the environment.
- Still other types of wastewater include water, which is used in the hold of ships for ballast. Conditions within the water storage can not only pollute the water with solids but also can cause growth of harmful microorganisms as well as transfer of harmful microorganisms from one geographical location to another geographical location as a ship picks up ballast water in one port and discharges the ballast at another port or at sea. Before the wastewater is discharged back into the sea or a reservoir the harmful microorganisms in the water, which is used as ballast, needs to be subjected to an antimicrobial treatment to kill the harmful microorganisms before the water is discharged.
- Briefly, the present invention comprises a method of killing microorganisms in wastewater with biocidal metal ions by elevating the concentration of available biocidal metal ions in the wastewater addition by including of an additive to the wastewater, which may or may not have any antimicrobial properties.
- In one example the invention includes a dispenser with an antimicrobial agent comprising a compound containing a hydantoin ring and a biocidal metal ion source
- In another example the invention includes method of killing microbes in wastewater by adding a source of biocidal metal ions to the body of wastewater together with a compound containing a hydantoin ring to enhance the biocidal metal ion concentration to a level effective to kill the microorganisms in the wastewater.
- In another example the compound containing a hydantoin ring may be tabletized, or be in liquid, powder or other solid form so the compound containing the hydantoin ring can be placed in a body of wastewater together with a source of biocidal metal ions to kill microorganisms the wastewater.
-
FIG. 1 discloses a system for treating wastewater; -
FIG. 2 shows the concentrations of silver with and without the addition of DMH -
FIG. 3 shows an example of a one-chamber dispenser; -
FIG. 4 shows an example of a two-chamber dispenser; and -
FIG. 5 shows a schematic of a hydantoin ring. -
FIG. 1 discloses awastewater treatment system 10 for recycling wastewater to a state where the water is either fit for human consumption, agricultural use or otherwise returned to the environment. Wastewater, of all types which includes but is not limited to residential wastewater, industrial wastewater, commercial wastewater and reservoir wastewater comes in various conditions and may include human waste, food scraps, oil, soaps and chemical. Household wastewater generally comes from household appliances, bathtubs, showers and toilets. Wastewater that is heavily polluted is often referred to as black water and household wastewater that does not include toilet waste is often referred to as greywater since, although polluted, it generally contains lesser amounts of pollutants. -
Wastewater treatment system 10 includes aholding tank 11 that receives wastewater from aninlet pipe 12, In one application the wastewater can be from commercial, industrial or households septic systems and can be either greywater or blackwater. After arriving in theholding tank 11 the wastewater is pumped to awater treatment station 12 where solid or particle pollutants are removed from the wastewater. Solids may be removed through various methods including centrifuges or gravitation settling. The solid pollutants are removed throughoutlet 12 a and the wastewater with the solid pollutants removed is then pumped throughpipe 15 to anotherwater treatment station 14 where unwanted liquids such as oils or soaps are removed from the wastewater and discharged throughoutlet 14 a. Smaller particles or unwanted liquids may be removed by filters or the like. Once the unwanted liquids are removed from the wastewater the wastewater is pumped towater purification station 16 throughpipe 17. - The amount and type of treatment of the wastewater in
purification chamber 16 depends on the eventual use of water inpurification chamber 16. For example, if the water inchamber 16 is to be used for human consumption the unwanted organisms in the wastewater need to be killed to render the water suitable for human consumption. One of the effective ways of killing harmful organisms, such as bacteria, in wastewater is the use of biocidal metals that release heavy metals ions and particularly heavy metals ions such as silver ions. Although silver ions are effective in killing harmful unwanted organisms the solubility of silver ions in water is limited and hence the effectiveness in quickly and effectively killing harmful bacterial is also limited. - While wastewater treatment involves the removal of pollutants in the wastewater the type of wastewater treatment required will depend on the type of wastewater being processed as well as the final use for the wastewater. For example, if the wastewater is to be used for human consumption one of the final processing steps includes the killing of harmful organism in the wastewater. In the process described herein wastewater is purified either partly or wholly through the use of a heavy metal ion donor that releases heavy metal ions such as silver ions. Although silver ions are effective in killing harmful organisms the low solubility of the silver ions in water limits the effectiveness of the silver ions to provide an effective and quick kill of harmful organisms in the wastewater. In the process described herein the effectiveness of the metal ions, particularly the silver ions, is enhanced through increasing the solubility of the silver ions by addition of a compound containing a hydantoin ring.
-
FIG. 5 shows a schematic of the structure of a hydantoin ring with carbon and nitrogen atoms joined in a five-sided ring. An oxygen atom is attached to two of the carbons in the hydantoin ring. The lines extending from the third carbon atom and the nitrogen atom indicate that other atoms could be attached thereto. For example, in a compound containing a hydantoin ring, such as DMH (5,5-dimethylhydantoin), two methyl groups would be attached to the carbon atom an a hydrogen atom would be attached to each of the two nitrogen atoms. - Tests performed by the inventor have demonstrated that two halogenated hydantoins such as Bromochlorodimethylhydantoin (BCDMH) and Dibromodimethylhydantoin (DBDMH) when combined with a metal ion donor may be used in pools and spas to kill microorganisms (U.S. Pat. No. 7,347,934),
- It has been found that a compound containing a hydantoin ring such as 5,5-dimethylhydantoin (DMH), which lacks antimicrobial properties, has the ability to interact with a source of metal ions to increase the solubility of the silver in wastewater to increase the effectiveness of the antimicrobial process in the wastewater. It has also been found that compounds containing a hydantoin ring, which have antimicrobial properties, such as Bromochlorodimethylhydantoin (BCDMH) and Dichlorodimethylhydatoin (DCDMH) Dibromodimethylhydantoin (DBDMH) or silverdimethylhydantoin (AgDMH) also interact to increase the solubility of silver in the presence of water. While a number of compounds with a hydantoin ring may be used as a practical matter one may want to avoid those compounds where the group or groups on the compound may have an adverse effect on the sanitized product.
- Examples of other well known compounds wherein the compound contains a hydantoin ring include 1-hydroxymethyl-5,5-dimethlyl hydantoin, glycolyurea and Copper hydantoin, Hydantoin-5-acetic acid, and Imidazolidines including parabanic acid, 2-Thiohydantoin, hydantoin purum, hydantoin, 1-Aminohydantoin hydrochloride, 2-Imidazolidone, 2-Imidazolidone purum, 2-Imidazolidinethione, 2-hydrazino-2-imidazoline hydrobromide, 2-oxo-1-imidazolidinecarbonyl chloride, 1-methyl hydantoin, 5-methylhydandtoin, 2-imidazolidone-4-carboxylic acid, allantoin, allantoin purum, creatinine anhydrous, creatinine biochemika, creatinine hydrochloride, 2-methyl-2-imidazoline, 2-methylithio-2-imdazoline hydrodide, 3-bromo-1-chlor-5-5-dimethlyhydantoin, 1-3-dibromo-5,5-dimethly hydantoin purium, 1-3-dichlorol-5,5-dimethylhydantoin, 1,3-dichlor-5,5-dimethylhydantoin, hydantoin-5-acetic acid. 2-chlorocarbonyl-1-methanesulfonyl-2imidaz olidinone. 5,5-dimethylhydantoin purum. 5,5-dimethylhydantoin, 2-imino-1-imidaolidineacetic acid, 1,3-dimethyl-2-imidazolidinone puriss, 1,3-dimethly-2-imidazolidinone purum, 1,3-dimethyl-2-imidazolidinone, 1-(2-hydroxyethyl)-2-imdazolinone, 1,5,5-trimethlylhydantoin, 5-ethyl-5-methylhydantoin, 2-phenyl-2-imidazoline purum, 2-(4,5-dihydro-1h-imidazoyl)-2-phenol, 4-(4,5-dihydro-1H-imidazol-2yl)phenylamine, 5-methyl-5-phentylhydantoin, 2-benzyl imidazoline, 4-(4-methyl-4,5-dihydro-1H-imidazol-2-yl)phenyl, Imidazolidinyl urea, 4-hydroxymephenyloin, triethoxy-3-(2-imidazolin-1-yl)propysiliane purum, 1, (p-tosyl)-3,4,4-trimethylimidazolidine, naphazoline nitrate puriss, 5,5,diphenyl-2-thiohydantoin, 5-(4-hydroxyphenyl)-50phenylhydantion, 5-(p-methylphenyl)-5-phenyhydantoin, 1,3,bisbensyl-2-oxoimidazoline-4,5-dicarboxylic acid. Other examples of hydantoins are listed in European patent EP0780125 which is hereby incorporated by reference. The above list compounds with a hydantoin ring is illustrative and no limitation thereto is intended.
- Tests of a silver ion donor in the presence of DMH in a body of water reveals that the dissolved silver concentrations are higher than anticipated when compared to a body of water with the silver ion donor but without the DMH. The results suggest that DMH interacts with silver to form a soluble complex even if the source(s) of silver are from insoluble salts such as silver bromide, which in some cases may be derived from silver chloride:
- In order to verify that a compound containing a hydantoin ring, such as, DMH interacts to increase the solubility of insoluble silver in a body of water, a test was performed using either silver chloride or silver bromide as the donor of silver metal ions. The test demonstrated the enhancement of the silver ion concentration in a water environment when DMH is used in combination with the source of silver ions even though the DMH lacked any independent antimicrobial properties.
- Silver bromide was initially prepared from a saturated sodium bromide solution, combined with silver nitrate in solution. The yellow precipitate, silver bromide, was than purified by filtration and washing. Additionally, the solid was allowed to dry before use.
- A buffer system having a pH of 7.41 was prepared by adding Fisherbrand® potassium phosphate monobasic-sodium phosphate dibasic buffer to 2 Erlenmeyer flasks filled with 1000 mL of purified water. The first flask was treated with 1.12 grams of 5,5-dimethylhydantoin (DMH) and marked solution “C” (with DMH) and the second flask was left untreated and marked solution “D” (without DMH) for control. In regards to the 5,5-dimethylhydantoin (DMH), the 5,5-dimethylhydantoin (DMH) comprised 97% reagent grade was obtained from Aldrich® (CAS No. 77-71-4, Cat. No. D161403-1KG).
- After the initial set-up, approximately 0.10 grams of dried silver bromide was introduced into a dialysis tubing (Fisherbrand®, 45 mm, MWCO 12,000-14,000) along with purified water. The ends of the dialysis tubing were clamped to contain the silver bromide and purified water. Next, the outside of the dialysis tubing was rinsed several times to ensure that silver bromide residue was not on the outside of the dialysis tubing. A string was then tied to one clamp, and one tube was introduced into each flask. A magnetic stir bar was used to mix the solutions.
- During the period of the test, a 100 ml sample were removed from solution “D” (without DMH) and solution “C” (with DMH) at weekly intervals and analyzed for their pH using Orin Perphect Meter 370 and analyzed for their silver ion concentrations using atomic absorption spectrometry.
-
FIG. 2 shows a table containing a list of the dissolved silver concentration, in parts per billion (ppb) obtained from the 100 ml samples for solution “D” (without DMH) and solution “C” (with DMH) at each of their respective weekly time intervals. The average concentration of dissolved silver for solution “C” (with DMH) was 86 ppb while solution “D” (without DMH) had an average concentration of dissolved silver of 4.7 ppb. - A week after the start date, the concentration of dissolved silver for solution D (without DMH) was at 4.3 ppb, while the concentration of dissolved silver for solution C (with DMH) was at 2.8 ppb. By the end of the testing, 6 weeks later, the concentration of dissolved silver for solution C (with DMH) had increase to 220 ppb, while the concentration of dissolved silver for solution D (without DMH) was 7.1 ppb. That is, by the end of the 6 weeks test, the concentration of dissolved silver was at least 30-fold greater in solution C (with DMH) then for solution D, (without DMH).
- In summary, the results of the above testing confirmed that in a solution containing silver bromide, the presence of compound containing a hydantoin ring, such as DMH, leads to a higher dissolved silver concentrations than compared to a control solution containing silver bromide without the presence of the DMH. These results suggest that compounds containing a hydantoin ring, which may not have any antimicrobial properties, can interact with silver to form a soluble complex even if the source of silver comprises an extremely insoluble silver salt such as silver bromide.
- In regards to generating a level of silver ions in a body of water, the King Technology, Inc. Frog® Mineral Cartridge is known to provide silver ions in the form of solid silver chloride (AgCl) distributed over a porous matrix. Water flowing through the matrix comes into contact with the AgCl resulting in the release of soluble silver ions to water. DMH was also released into the water resulting in the formation of ionic-hydantoin structures. It would be anticipated that soluble silver ions would be depleted from water through the formation of silver bromide, an insoluble salt. However, as shown in
FIG. 2 after the DMH was added to the water, the actual silver concentrations were higher than the calculated theoretical silver concentration. - Referring to
FIGS. 3 and 4 ,FIG. 3 shows adispenser 20 having ahousing 21 containing acompartment 22 therein for the compound containing the hydantoin ring and a source of biocidal metal ions such as silver ions. Located incompartment 22 is acompound 23 containing a hydantoin ring such as DMH and a biocidal component such a biocidal metal for generating biocidal metal ions into a body of wastewater. Although various types of biocidal metal such as zinc or copper may be use, the preferred biocidal metals comprise silver, silver alloy or some combination thereof, because of the recognized bactericidal, viricidal, and algaecidal properties of silver. The biocidal metals can be introduced as metallic, zero valence material, or as metal ions that can be introduced into the water by dissolution of soluble metal salts, or by the dissolution of the metal itself. For example, silver ion can be introduced into the water through the dissolution of silver nitrate, or through the dissolution of metallic silver as the result of conversion to silver oxide and subsequent conversion of the oxide to more soluble silver species. Mixtures of different salts, or of salts with metallic material, may be combined together to provide the necessary concentration of metal ions in the water. In the embodiment ofFIG. 3 , the biocidal metal is in a dry or inactive state and comprises either metallic silver or a source of silver ions, such as silver chloride 24. Similarly, the compound containing the hydantoin ring is also in a dry or inactive state, with both compound containing the hydantoin ring and the silver chloride entering into an active state in the presence of wastewater. A set ofopenings 25 allows water access tocompartment 22 and to the source of the compound containing ahydantoin ring 23 and the source of silver ions 24. - It is noted that various insoluble or slightly soluble transition metal salts may also be used in the present invention as a source of silver ions. Examples of insoluble or slightly soluble transition metal salts suitable for use in the present invention include, but are not limited to, AgCl, AgBr, AgI, Ag2S, Ag3PO4, NaAg2PO4, CuS, and NaCuPO4. Other examples of silver compounds include, but are not limited to, AgNO3, Ag2CO3, AgOAc, Ag2SO4, Ag2O, [Ag(NH3)2]Cl, [Ag(NH3)2]Br, [Ag(NH3)2]I, [Ag(NH3)2]NO3, [Ag(NH3)2]2SO4, silver acetoacetate a silver benzoate, a silver carboxylate, silver amine complexes such as [Ag(NR3)2]X, where R is an alkyl or aryl group or substituted alkyl or aryl group and X is an anion such as, but not limited to, Cl−, Br−, I−, OAc−, NO3 − and SO4 2−.
-
FIG. 4 shows a further example of wasterwater treating system including adispenser 26 having afirst housing 27 containing acompartment 28 and asecond housing 29 with acompartment 30 therein. Located incompartment 28 is a silver ion donor such asmetallic silver 31 and located incompartment 30 is a source ofcompound 32 containing a hydantoin ring such as DMH. A set ofopenings 33 allows water access tocompartment 28 and to themetallic silver 31. Similarly, a set ofopenings 34 allows water access tocompartment 30 and the source of DMH. - Although the use of the silver ion donor such as silver, silver oxide, silver salt, or a combination thereof have been disclosed in the present invention, various types of silver alloys may also be used. The silver may be used standing along in its pure/elemental or alloyed form or coated or impregnated to a substrate and placed in
compartment 28. In addition, other types of silver ion donors, other types of transition metal, a transition metal oxide, or a combination thereof, and other alternative bactericides whose solubility can be changed in the presence of DMH can also be used in the present invention. - In regards to the source of
DMH FIGS. 3 and 4 , note thatFIG. 3 shows source of compound containing ahydantoin ring 22 in particle form with the aforementioned particles having an initial size that is larger than the size of opening 23 to prevent the particles from escaping throughopening 23.FIG. 3 shows source of compound containing ahydantoin ring 23 in tablet form. In regards to the tablets, it is noted that various types of material, including but not limited to microcrystalline cellulose (MCC), may be used as a binder in the formation of the santizing tablets which are tabletized with a metal ion donor so that both the compound containing a hydantoin ring and the metal ion donor can be placed in the body of fluid to be treated. - It is also noted that the preferred level of the compound containing a hydantoin ring in his case which is DMH is present in the body of wastewater is between 5 and 25 ppm with the DMH and the source of silver cooperating to maintain a level of silver ions present in the amount of 1 to 3 ppb and/or alternatively cooperating to maintain a level of silver ions present to sustain a standard plate count at 35 degrees F. of less than 200 colonies per milliliter.
- Thus the invention includes an antimicrobial agent for killing microorganisms in a body of wastewater wherein the antimicrobial agent includes a source of biocidal metal ions releasable into the body of wastewater to generate an antimicrobial level of biocidal metals that may be insufficient to kill the microorganisms in the body of wastewater and a compound containing a hydantoin ring releasable into the body of wastewater wherein the compound containing the hydantoin ring increases the antimicrobial level of biocidal metal ions in the body of wastewater to a biocidal level sufficient to kill microorganism in the wastewater.
- The invention also includes the step of placing the
dispenser compound 23 containing a hydantoin ring, and the source ofsilver ions 24, 31 in the body of wastewater and allowing water to come into contact with theDMH silver ion 24, 31 to periodically release DMH and silver ions into the body of wastewater. As the DMH is released into the body of wastewater, the DMH is carried to the source ofsilver ions 24, 31 and interacts with the source ofsilver 24, 31 to increase the solubility of the silver ions to allow for the release of more silver ions into the body of wastewater than if the source ofsilver ions 24, 31 alone thereby increasing the level of silver ions to a level sufficient to kill the microorganisms in the wasterwater. - The invention also include a method of treating a body of wastewater to kill microorganisms by enhancing the microbial agents comprising the steps of (1) adding a
biocidal component dimethylhydantoin biocidal component dispenser biocidal component dimethylhydantoin biocidal component dimethylhydantoin dimethylhydantoin - The invention further includes a method of treating a body of wastewater to kill microorganisms by increasing the effectiveness of an antimicrobial agents comprising the steps of: (1) adding a source of
biocidal metal dimethylhydantoin biocidal metal metallic silver alloy dispenser biocidal metal dimethylhydantoin biocidal metal dimethylhydantoin substrate pure silver - Thus, as described herein one example a wastewater antimicrobial agent may include a biocidal metal selected from the group consisting of silver chloride, a metallic silver alloy, pure silver or a substrate impregnated with metallic silver and the compound containing the hydantoin ring where the compound containing the hydantoin ring may be either a non-halogenated hydantoin such as 5,5-dimethylhydantoin (DMH) or a halogenated hydantoin including Bromochlorodimethylhydantoin (BCDMH) or Dichlorodimethylhydatoin (DCDMH) or combinations thereof and the compound containing the hydantoin ring is in either a liquid state or a dry state including, powder, solid, granules, pellets or combinations thereof.
Claims (20)
1. A method for treatment of wastewater containing solid pollutants comprising:
removal of the solid pollutants from the wastewater;
killing microorganisms in the wastewater after removal of the solid pollutants by adding a biocidal component to a body of wastewater; and
enhancing the effectiveness of the biocidal component in the wastewater by adding a compound containing a hydantoin ring to the wastewater, which may or may not have any antimicrobial properties, to thereby enhance the effectiveness of the biocidal component by increasing the solubility of the biocidal component in the body of wastewater.
2. The method of treatment of wastewater of claim 1 wherein the step of adding a biocidal component to the body of wastewater comprises adding a transition metal, a transition metal oxide, a transition metal salt, or a combination thereof to the body of wastewater.
3. The method of treatment of wastewater of claim 2 wherein the step of adding the transition metal, the transition metal oxide, the transition metal salt, or a combination thereof to the body of wastewater comprises adding silver, silver oxide, silver salt, or a combination thereof to the body of wastewater or a substrate that has been coated or impregnated with metallic silver, silver salt, or a combination thereof.
4. The method of treatment of wastewater of claim 1 wherein the step of adding the biocidal component to the body of wastewater comprises adding a silver-containing material, a silver alloy or a silver nitrate to the body of wastewater and the compound containing the hydantoin ring lacks biocidal effectiveness when used alone
5. The method of treatment of wastewater of claim 1 wherein adding the compound containing a hydantoin ring is a compound selected from the group consisting of dimethylhydantoin (DMH) Bromochlorodimethylhydantoin (BCDMH), Dichlorodimethylhydatoin (DCDMH), Dibromodimethylhydantoin (DBDMH).
6. The method of treatment of waste water of claim 1 including the step of placing a dispenser containing both the biocidal component and the compound containing a hydantoin ring in the wastewater and allowing the wastewater to come into contact with both the biocidal component and the compound containing a hydantoin ring.
7. The method of treatment of waste water of claim 1 wherein step of adding a compound containing a hydantoin ring includes adding a concentration of 5,5-dimethylhydantoin to the body of wastewater to obtain a final concentration of at least 5 ppm 5,5-dimethylhydantoin.
8. The method of treatment of wastewater of claim 1 wherein the compound containing a hydantoin contains a halogen.
9. The method of treatment of claim 1 wherein the step of adding a biocidal component to a body of wastewater comprises adding the biocidal component to the wastewater after unwanted liquid pollutants are removed from the wastewater.
10. A method of treating a body of wastewater to kill microorganisms therein by increasing the effectiveness of an antimicrobial agent comprising the steps of:
adding a source of biocidal metal to the body of wastewater to generate biocidal metal ions in the body of wastewater; and
adding a compound containing a hydantoin ring to the body of wastewater, where the compound containing a hydantoin ring may or may not have any antimicrobial properties, to interact with the source of biocidal metal to increase an availably of biocidal metal ions in the body of wastewater.
11. The method of treatment of claim 10 wherein the wastewater is greywater or ballast water.
12. The method of treatment of wastewater of claim 10 wherein the source of biocidal metal ions comprises a source of silver ions and the compound containing the hydantoin ring comprises 5,5-dimethylhydantoin and the level of 5,5-dimethylhydantoin in the body of wastewater is at least 5 ppm.
13. The method of treatment of wastewater of claim 10 wherein the step of adding the source of biocidal metal to the body of wastewater comprises adding a source of metallic silver or metallic silver alloy to the body of wastewater.
14. The method of treatment of wastewater of claim 12 including the step of placing a dispenser containing both the source of biocidal metal and the 5,5-dimethylhydantoin in the body of wastewater and allowing wastewater to come into contact with both the source of biocidal metal and the 5,5-dimethylhydantoin.
15. The method of treatment of wastewater of claim 11 wherein the step of adding the source of biocidal metal to the body of wastewater comprises adding silver chloride to the body of wastewater.
16. A wastewater antimicrobial dispenser for killing microorganisms in a body of wastewater comprising;
a dispenser containing a source of biocidal metal ions releasable into the body of wastewater to generate a santizing level of biocidal metals insufficient to kill the microorganisms in the body of wastewater and a compound containing a hydantoin ring releasable into the body of wastewater wherein the compound containing the hydantoin ring increases the antimicrobial level of biocidal metal ions in the body of wastewater to a biocidal level sufficient to kill microorganism in the wastewater.
17. The wastewater antimicrobial dispenser of claim 16 including
a first housing having a water accessible compartment containing the biocidal metal; and
a second housing having a water accessible compartment containing the compound containing a hydantoin ring.
18. The wastewater antimicrobial dispenser of claim 16 wherein the source of biocidal metal comprises silver chloride and the compound containing a hydantoin ring comprises 5,5-di methyl hydantoin.
19. The wastewater antimicrobial dispenser of claim 16 wherein the biocidal metal is selected from the group consisting of a metallic silver alloy, pure silver or a substrate impregnated with metallic silver and the compound containing the hydantoin ring is either 5,5-dimethylhydantoin (DMH) Bromochlorodimethylhydantoin (BCDMH) or Dichlorodimethylhydatoin (DCDMH) or combinations thereof wherein the compound containing the hydantoin ring is either a powder, a liquid, a solid or combinations thereof.
20. The wastewater antimicrobial dispenser of claim 16 wherein the compound containing a hydantoin ring lacks biocidal effectiveness to kill microorganisms.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/592,699 US20100140185A1 (en) | 2008-12-05 | 2009-12-01 | Wastewater treatment |
US14/049,041 US20140124426A1 (en) | 2009-12-01 | 2013-10-08 | Wastewater treatment |
US14/868,365 US20160096752A1 (en) | 2008-12-05 | 2015-09-28 | Wastewater treatment |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20095808P | 2008-12-05 | 2008-12-05 | |
US12/592,699 US20100140185A1 (en) | 2008-12-05 | 2009-12-01 | Wastewater treatment |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/800,692 Continuation-In-Part US8591748B2 (en) | 2004-08-26 | 2010-05-20 | Water treatment |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/049,041 Continuation-In-Part US20140124426A1 (en) | 2009-12-01 | 2013-10-08 | Wastewater treatment |
US14/868,365 Continuation US20160096752A1 (en) | 2008-12-05 | 2015-09-28 | Wastewater treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100140185A1 true US20100140185A1 (en) | 2010-06-10 |
Family
ID=42229568
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/592,699 Abandoned US20100140185A1 (en) | 2008-12-05 | 2009-12-01 | Wastewater treatment |
US12/631,059 Active 2031-12-28 US8573060B2 (en) | 2008-12-05 | 2009-12-04 | Particle focusing within a microfluidic device using surface acoustic waves |
US14/868,365 Abandoned US20160096752A1 (en) | 2008-12-05 | 2015-09-28 | Wastewater treatment |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/631,059 Active 2031-12-28 US8573060B2 (en) | 2008-12-05 | 2009-12-04 | Particle focusing within a microfluidic device using surface acoustic waves |
US14/868,365 Abandoned US20160096752A1 (en) | 2008-12-05 | 2015-09-28 | Wastewater treatment |
Country Status (2)
Country | Link |
---|---|
US (3) | US20100140185A1 (en) |
WO (1) | WO2010065868A2 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110174743A1 (en) * | 2009-09-18 | 2011-07-21 | The Texas A & M University System | Hybrid composites for contaminated fluid treatment |
US20130327419A1 (en) * | 2012-02-22 | 2013-12-12 | Applied Silver, Inc. | Antimicrobial device |
CN106556561A (en) * | 2016-11-28 | 2017-04-05 | 中国科学院苏州生物医学工程技术研究所 | A kind of fluid particles motion control device |
US9689106B2 (en) | 2013-12-06 | 2017-06-27 | Applied Silver, Inc. | Antimicrobial fabric application system |
CN109433285A (en) * | 2018-12-27 | 2019-03-08 | 苏州纳葛诺斯生物科技有限公司 | Micro-and nano-particles micro-fluidic chip based on surface acoustic wave |
US10351807B2 (en) | 2015-08-21 | 2019-07-16 | Applied Silver, Inc. | Systems and processes for treating textiles with an antimicrobial agent |
US10377648B2 (en) | 2009-09-18 | 2019-08-13 | The Texas A&M University System | Selenium removal using aluminum salt at conditioning and reaction stages to activate zero-valent iron (ZVI) in pironox process |
US10640403B2 (en) | 2013-08-15 | 2020-05-05 | Applied Silver, Inc. | Antimicrobial batch dilution system |
US10760207B2 (en) | 2017-03-01 | 2020-09-01 | Applied Silver, Inc. | Systems and processes for treating textiles with an antimicrobial agent |
US11084742B2 (en) | 2014-12-19 | 2021-08-10 | The Texas A&M University System | Activated hybrid zero-valent iron treatment system and methods for generation and use thereof |
US11618696B2 (en) | 2013-08-15 | 2023-04-04 | Applied Silver, Inc. | Antimicrobial batch dilution system |
Families Citing this family (153)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7311476B2 (en) | 2003-10-30 | 2007-12-25 | Cytonome, Inc. | Multilayer hydrodynamic sheath flow structure |
US9918740B2 (en) | 2006-02-27 | 2018-03-20 | Biomet Manufacturing, Llc | Backup surgical instrument system and method |
US9173661B2 (en) | 2006-02-27 | 2015-11-03 | Biomet Manufacturing, Llc | Patient specific alignment guide with cutting surface and laser indicator |
US9113971B2 (en) | 2006-02-27 | 2015-08-25 | Biomet Manufacturing, Llc | Femoral acetabular impingement guide |
US9339278B2 (en) | 2006-02-27 | 2016-05-17 | Biomet Manufacturing, Llc | Patient-specific acetabular guides and associated instruments |
US8591516B2 (en) | 2006-02-27 | 2013-11-26 | Biomet Manufacturing, Llc | Patient-specific orthopedic instruments |
US8092465B2 (en) | 2006-06-09 | 2012-01-10 | Biomet Manufacturing Corp. | Patient specific knee alignment guide and associated method |
US8603180B2 (en) | 2006-02-27 | 2013-12-10 | Biomet Manufacturing, Llc | Patient-specific acetabular alignment guides |
US9907659B2 (en) | 2007-04-17 | 2018-03-06 | Biomet Manufacturing, Llc | Method and apparatus for manufacturing an implant |
US20150335438A1 (en) | 2006-02-27 | 2015-11-26 | Biomet Manufacturing, Llc. | Patient-specific augments |
US8377066B2 (en) | 2006-02-27 | 2013-02-19 | Biomet Manufacturing Corp. | Patient-specific elbow guides and associated methods |
US9289253B2 (en) | 2006-02-27 | 2016-03-22 | Biomet Manufacturing, Llc | Patient-specific shoulder guide |
US9345548B2 (en) | 2006-02-27 | 2016-05-24 | Biomet Manufacturing, Llc | Patient-specific pre-operative planning |
US7967868B2 (en) | 2007-04-17 | 2011-06-28 | Biomet Manufacturing Corp. | Patient-modified implant and associated method |
US8407067B2 (en) | 2007-04-17 | 2013-03-26 | Biomet Manufacturing Corp. | Method and apparatus for manufacturing an implant |
US8608748B2 (en) | 2006-02-27 | 2013-12-17 | Biomet Manufacturing, Llc | Patient specific guides |
US8608749B2 (en) | 2006-02-27 | 2013-12-17 | Biomet Manufacturing, Llc | Patient-specific acetabular guides and associated instruments |
US8568487B2 (en) | 2006-02-27 | 2013-10-29 | Biomet Manufacturing, Llc | Patient-specific hip joint devices |
US10278711B2 (en) | 2006-02-27 | 2019-05-07 | Biomet Manufacturing, Llc | Patient-specific femoral guide |
US9795399B2 (en) | 2006-06-09 | 2017-10-24 | Biomet Manufacturing, Llc | Patient-specific knee alignment guide and associated method |
GB0914762D0 (en) | 2009-08-24 | 2009-09-30 | Univ Glasgow | Fluidics apparatus and fluidics substrate |
US8691145B2 (en) | 2009-11-16 | 2014-04-08 | Flodesign Sonics, Inc. | Ultrasound and acoustophoresis for water purification |
US8956538B2 (en) | 2010-06-16 | 2015-02-17 | Flodesign Sonics, Inc. | Phononic crystal desalination system and methods of use |
US9421553B2 (en) | 2010-08-23 | 2016-08-23 | Flodesign Sonics, Inc. | High-volume fast separation of multi-phase components in fluid suspensions |
EP2608878A4 (en) | 2010-08-23 | 2017-11-15 | President and Fellows of Harvard College | Acoustic waves in microfluidics |
US9968376B2 (en) | 2010-11-29 | 2018-05-15 | Biomet Manufacturing, Llc | Patient-specific orthopedic instruments |
GB201103211D0 (en) * | 2011-02-24 | 2011-04-13 | Univ Glasgow | Fluidics apparatus, use of fluidics apparatus and process for the manufacture of fluidics apparatus |
US9241745B2 (en) | 2011-03-07 | 2016-01-26 | Biomet Manufacturing, Llc | Patient-specific femoral version guide |
WO2012135663A2 (en) * | 2011-03-31 | 2012-10-04 | University Of South Florida | Two-stage microfluidic device for acoustic particle manipulation and methods of separation |
US9066734B2 (en) | 2011-08-31 | 2015-06-30 | Biomet Manufacturing, Llc | Patient-specific sacroiliac guides and associated methods |
US9656263B2 (en) * | 2011-09-28 | 2017-05-23 | Acousort Ab | System and method to separate cells and/or particles |
DE102011118742A1 (en) * | 2011-11-17 | 2013-05-23 | Forschungszentrum Jülich GmbH | Detector for magnetic particles in a liquid |
EP2809428A4 (en) * | 2012-01-31 | 2015-11-04 | Penn State Res Found | Microfluidic manipulation and sorting of particles using tunable standing surface acoustic wave |
US10370635B2 (en) | 2012-03-15 | 2019-08-06 | Flodesign Sonics, Inc. | Acoustic separation of T cells |
US10322949B2 (en) | 2012-03-15 | 2019-06-18 | Flodesign Sonics, Inc. | Transducer and reflector configurations for an acoustophoretic device |
US9688958B2 (en) | 2012-03-15 | 2017-06-27 | Flodesign Sonics, Inc. | Acoustic bioreactor processes |
US9745548B2 (en) | 2012-03-15 | 2017-08-29 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US9272234B2 (en) | 2012-03-15 | 2016-03-01 | Flodesign Sonics, Inc. | Separation of multi-component fluid through ultrasonic acoustophoresis |
US9796956B2 (en) | 2013-11-06 | 2017-10-24 | Flodesign Sonics, Inc. | Multi-stage acoustophoresis device |
US9752114B2 (en) | 2012-03-15 | 2017-09-05 | Flodesign Sonics, Inc | Bioreactor using acoustic standing waves |
US9752113B2 (en) | 2012-03-15 | 2017-09-05 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US10689609B2 (en) | 2012-03-15 | 2020-06-23 | Flodesign Sonics, Inc. | Acoustic bioreactor processes |
US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US9458450B2 (en) * | 2012-03-15 | 2016-10-04 | Flodesign Sonics, Inc. | Acoustophoretic separation technology using multi-dimensional standing waves |
US9783775B2 (en) | 2012-03-15 | 2017-10-10 | Flodesign Sonics, Inc. | Bioreactor using acoustic standing waves |
US9950282B2 (en) | 2012-03-15 | 2018-04-24 | Flodesign Sonics, Inc. | Electronic configuration and control for acoustic standing wave generation |
US10953436B2 (en) | 2012-03-15 | 2021-03-23 | Flodesign Sonics, Inc. | Acoustophoretic device with piezoelectric transducer array |
US10967298B2 (en) | 2012-03-15 | 2021-04-06 | Flodesign Sonics, Inc. | Driver and control for variable impedence load |
US9567559B2 (en) | 2012-03-15 | 2017-02-14 | Flodesign Sonics, Inc. | Bioreactor using acoustic standing waves |
US10737953B2 (en) | 2012-04-20 | 2020-08-11 | Flodesign Sonics, Inc. | Acoustophoretic method for use in bioreactors |
WO2013156081A1 (en) * | 2012-04-20 | 2013-10-24 | Foss Analytical A/S | Microfluidic impedance flow cytometer |
US11324873B2 (en) | 2012-04-20 | 2022-05-10 | Flodesign Sonics, Inc. | Acoustic blood separation processes and devices |
JP6110484B2 (en) * | 2012-06-21 | 2017-04-05 | エスティーシー. ユーエヌエムStc.Unm | Spatial correlation focusing from multiple sample streams excited by a line focusing light source |
WO2014004630A1 (en) * | 2012-06-27 | 2014-01-03 | President And Fellows Of Harvard College | Control of entities such as droplets and cells using acoustic waves |
JP6025982B2 (en) * | 2012-08-01 | 2016-11-16 | ザ・ペン・ステート・リサーチ・ファンデーション | Efficient separation and manipulation of particles and cells |
US20150298157A1 (en) * | 2012-10-26 | 2015-10-22 | President And Fellows Of Harvard College | Systems and methods for droplet production and manipulation using acoustic waves |
US9757699B2 (en) | 2012-11-27 | 2017-09-12 | The Penn State Research Foundation | Spatiotemporal control of chemical microenvironment using oscillating microstructures |
KR101356933B1 (en) * | 2012-12-28 | 2014-01-29 | 고려대학교 산학협력단 | Apparatus and method for separating micro-nano scale particles using surface acoustic wave-based microfluidic chromatography |
WO2014133451A1 (en) * | 2013-02-28 | 2014-09-04 | Acousort Ab | System and method to analyze non-spherical cells |
WO2014138715A1 (en) * | 2013-03-08 | 2014-09-12 | Duke University | Devices, systems, and methods for acoustically -enhanced magnetophoresis |
NZ743491A (en) | 2013-03-14 | 2020-03-27 | Cytonome St Llc | Hydrodynamic focusing apparatus and methods |
US20140342471A1 (en) * | 2013-05-20 | 2014-11-20 | Varian Semiconductor Equipment Associates, Inc. | Variable Doping Of Solar Cells |
KR101492332B1 (en) * | 2013-08-01 | 2015-02-13 | 고려대학교 산학협력단 | Specimen focusing apparatus |
GB201314533D0 (en) | 2013-08-14 | 2013-09-25 | Univ Leeds | Method and apparatus for manipulating particles |
US9745569B2 (en) | 2013-09-13 | 2017-08-29 | Flodesign Sonics, Inc. | System for generating high concentration factors for low cell density suspensions |
US10870175B2 (en) | 2013-09-18 | 2020-12-22 | Cytonome/St, Llc | Microfluidic flow-through elements and methods of manufacture of same |
WO2015057716A1 (en) * | 2013-10-15 | 2015-04-23 | The Penn State Research Foundation | Acoustic manipulation process and acoustic manipulation device |
AU2014336971B2 (en) * | 2013-10-17 | 2020-03-26 | Royal Melbourne Institute Of Technology | Piezoelectric actuation platform |
US9963693B2 (en) | 2013-10-21 | 2018-05-08 | Biomet Biologics, Llc | Cell washing device using a wave |
WO2015058265A1 (en) * | 2013-10-25 | 2015-04-30 | Monash University | Virtual deterministic lateral displacement for particle separation using surface acoustic waves |
CA2935960C (en) | 2014-01-08 | 2023-01-10 | Bart Lipkens | Acoustophoresis device with dual acoustophoretic chamber |
KR101620154B1 (en) * | 2014-01-16 | 2016-05-12 | 고려대학교 산학협력단 | Apparatus for separating micro-nano scale particle using field-flow fractionation based on acoustic wave |
CN106536059B (en) | 2014-06-09 | 2019-01-11 | 阿森特生物纳米科技股份有限公司 | Control and sorting system for particle |
US10258987B2 (en) * | 2014-06-26 | 2019-04-16 | President And Fellows Of Harvard College | Fluid infection using acoustic waves |
US9744483B2 (en) | 2014-07-02 | 2017-08-29 | Flodesign Sonics, Inc. | Large scale acoustic separation device |
AU2015307593B2 (en) | 2014-08-28 | 2017-04-13 | Sysmex Corporation | Particle imaging apparatus and particle imaging method |
KR102210343B1 (en) | 2014-10-24 | 2021-02-02 | 라이프 테크놀로지스 코포레이션 | Acoustically settled liquid-liquid sample purification system |
GB201420061D0 (en) * | 2014-11-11 | 2014-12-24 | Univ Glasgow | Nebulisation of liquids |
WO2016115014A1 (en) * | 2015-01-12 | 2016-07-21 | Instrumentation Laboratory Company | Spatial separation of particles in a particle containing solution for biomedical sensing and detection |
US10343187B2 (en) | 2015-01-21 | 2019-07-09 | Utah Valley University Foundation, Inc. | System and method for harmonic modulation of standing wavefields for spatial focusing, manipulation, and patterning |
CN105987870A (en) * | 2015-02-10 | 2016-10-05 | 博奥生物集团有限公司 | Flow cell sorting system and its focusing detection method and fluidic chip |
US10488321B2 (en) | 2015-03-19 | 2019-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Devices and methods for high-throughput single cell and biomolecule analysis and retrieval in a microfluidic chip |
US10106770B2 (en) | 2015-03-24 | 2018-10-23 | Flodesign Sonics, Inc. | Methods and apparatus for particle aggregation using acoustic standing waves |
US9820868B2 (en) | 2015-03-30 | 2017-11-21 | Biomet Manufacturing, Llc | Method and apparatus for a pin apparatus |
US9855382B2 (en) | 2015-03-31 | 2018-01-02 | Biomet Biologics, Llc | Cell washing device using standing acoustic waves and a phantom material |
US9670477B2 (en) | 2015-04-29 | 2017-06-06 | Flodesign Sonics, Inc. | Acoustophoretic device for angled wave particle deflection |
US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
US11021699B2 (en) | 2015-04-29 | 2021-06-01 | FioDesign Sonics, Inc. | Separation using angled acoustic waves |
US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
CN106290492A (en) * | 2015-05-11 | 2017-01-04 | 宁波大学 | Driving component is easily-disassembled and cholera diagnosis device more capable of circulation |
CA2986238A1 (en) | 2015-05-20 | 2016-11-24 | Bart Lipkens | Acoustic manipulation of particles in standing wave fields |
CN106290856A (en) * | 2015-05-26 | 2017-01-04 | 宁波大学 | Four-way and the AIDS diagnosis micro fluidic device of Dual Drive coupling running |
CN106290930A (en) * | 2015-05-26 | 2017-01-04 | 宁波大学 | The hypotype swine flue multi-channel testing device of the Dual Drive coupling containing hydrophobic substrate |
CN106290933A (en) * | 2015-05-26 | 2017-01-04 | 宁波大学 | Double-unit system drives the cholera diagnosis micro flow control chip device of coupling running |
CN106290857A (en) * | 2015-05-26 | 2017-01-04 | 宁波大学 | Multichannel and the cholera diagnosis micro flow control chip device of Dual Drive coupling running |
CN106290932A (en) * | 2015-05-26 | 2017-01-04 | 宁波大学 | Comprise the AIDS diagnosis Multichannel device of the Dual Drive coupling of hydrophobic substrate |
CN106290931A (en) * | 2015-05-26 | 2017-01-04 | 宁波大学 | The hypotype swine flue detection Multichannel device of substrate is made with cheap hydrophobic material |
US9437184B1 (en) * | 2015-06-01 | 2016-09-06 | Baker Hughes Incorporated | Elemental artificial cell for acoustic lens |
US10161926B2 (en) | 2015-06-11 | 2018-12-25 | Flodesign Sonics, Inc. | Acoustic methods for separation of cells and pathogens |
US9663756B1 (en) | 2016-02-25 | 2017-05-30 | Flodesign Sonics, Inc. | Acoustic separation of cellular supporting materials from cultured cells |
US10226262B2 (en) | 2015-06-25 | 2019-03-12 | Biomet Manufacturing, Llc | Patient-specific humeral guide designs |
US10568647B2 (en) | 2015-06-25 | 2020-02-25 | Biomet Manufacturing, Llc | Patient-specific humeral guide designs |
WO2016210128A1 (en) * | 2015-06-25 | 2016-12-29 | Cytonome/St, Llc | Microfluidic device and system using acoustic manipulation |
CN112044720B (en) | 2015-07-09 | 2023-07-04 | 弗洛设计声能学公司 | Non-planar and asymmetric piezoelectric crystals and reflectors |
US11459540B2 (en) | 2015-07-28 | 2022-10-04 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
US11474085B2 (en) | 2015-07-28 | 2022-10-18 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
CN108472621B (en) | 2015-08-27 | 2022-04-29 | 哈佛学院院长及董事 | Acoustic wave sorting |
EP3352882B1 (en) | 2015-09-23 | 2019-05-22 | Aenitis Technologies | Multi-use acoustic levitation trap |
CN106556709A (en) * | 2015-09-24 | 2017-04-05 | 宁波大学 | The micro flow control chip device comprising hydrophobic substrate of coupling Dual Drive pattern |
CN106556708A (en) * | 2015-09-24 | 2017-04-05 | 宁波大学 | The micro flow control chip device containing hydrophobic substrate of two kinds of type of drive coupling runnings |
WO2017059604A1 (en) * | 2015-10-10 | 2017-04-13 | 中国科学院深圳先进技术研究院 | Microfluidic system and method of controlling particles based on artificially structured acoustic field |
US20170113222A1 (en) * | 2015-10-22 | 2017-04-27 | Owl biomedical, Inc. | Particle manipulation system with spiral focusing channel |
WO2017127686A1 (en) * | 2016-01-22 | 2017-07-27 | Carnegie Mellon University | Three-dimensional acoustic manipulation of cells |
KR101807256B1 (en) * | 2016-01-26 | 2017-12-08 | 한양대학교 에리카산학협력단 | Particle separator and method for separating particle |
US10054707B2 (en) * | 2016-04-15 | 2018-08-21 | Baker Hughes, A Ge Company, Llc | Bipolar acoustic hyperlens for dual-string thru-casing ultrasonic sensors |
US10710006B2 (en) | 2016-04-25 | 2020-07-14 | Flodesign Sonics, Inc. | Piezoelectric transducer for generation of an acoustic standing wave |
US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
US11085035B2 (en) | 2016-05-03 | 2021-08-10 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
EP3481361A1 (en) | 2016-05-03 | 2019-05-15 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
EP3463660A1 (en) * | 2016-05-24 | 2019-04-10 | Centre National De La Recherche Scientifique | Acoustic tweezers |
KR101891401B1 (en) * | 2016-08-12 | 2018-08-23 | 고려대학교 산학협력단 | Microfluidic device and method for fabricating thereof |
WO2018030609A1 (en) * | 2016-08-12 | 2018-02-15 | 고려대학교 산학협력단 | Microfluidic device and manufacturing method therefor |
WO2018075830A1 (en) | 2016-10-19 | 2018-04-26 | Flodesign Sonics, Inc. | Affinity cell extraction by acoustics |
CN106807459B (en) * | 2016-12-13 | 2023-06-27 | 中国科学院苏州生物医学工程技术研究所 | Microfluidic chip and preparation method and application thereof |
US10722310B2 (en) | 2017-03-13 | 2020-07-28 | Zimmer Biomet CMF and Thoracic, LLC | Virtual surgery planning system and method |
WO2018189040A1 (en) * | 2017-04-14 | 2018-10-18 | Ventana Medical Systems, Inc. | Size-based separation of dissociated fixed tissues |
RU174330U1 (en) * | 2017-04-27 | 2017-10-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный университет геосистем и технологий" (СГУГиТ) | Acoustic trap in a standing wave field based on two oncoming beams |
CN107102058A (en) * | 2017-05-05 | 2017-08-29 | 杭州电子科技大学 | It is a kind of to be imaged based on what surface acoustic wave drove without lens miniflow and its detecting system |
US11073465B2 (en) * | 2017-08-21 | 2021-07-27 | The Board Of Trustees Of The University Of Illinois | Real-time sensing of flowing nanoparticles with electro-opto-mechanics |
WO2019046483A1 (en) * | 2017-08-29 | 2019-03-07 | Duke University | Systems, methods, and structures for surface acoustic wave-based separation |
CN114900773A (en) | 2017-12-14 | 2022-08-12 | 弗洛设计声能学公司 | Acoustophoretic system, method for operating acoustophoretic system, and method for controlling acoustic transducer and acoustic system |
CN109985672B (en) * | 2017-12-29 | 2020-07-24 | 深圳先进技术研究院 | Microfluidic chip, device, system, control method and preparation method |
WO2019156687A1 (en) * | 2018-02-12 | 2019-08-15 | Hewlett-Packard Development Company, L.P. | Microfluidic flow sensor |
WO2019156711A1 (en) | 2018-02-12 | 2019-08-15 | Hewlett-Packard Development Company, L.P. | Devices to measure flow rates with movable elements |
DE102018104669A1 (en) * | 2018-03-01 | 2019-09-05 | Dionex Softron Gmbh | Use of an acoustic wave in a chromatography system |
US11571696B2 (en) | 2018-03-03 | 2023-02-07 | Applied Cells Inc. | Biological entity separation device and method of use |
US10449553B2 (en) | 2018-03-03 | 2019-10-22 | Yuchen Zhou | Magnetic biological entity separation device and method of use |
US11007502B2 (en) * | 2018-05-03 | 2021-05-18 | Chevron Phillips Chemical Company Lp | Methods and systems for capturing particulates |
US20210362156A1 (en) * | 2018-07-16 | 2021-11-25 | Hewlett-Packard Development Company, L.P. | Separations of focused particle flows |
CN109507008B (en) * | 2018-10-24 | 2020-02-14 | 西安交通大学 | Micro-droplet rapid solidification device based on surface acoustic wave droplet micro-fluidic chip |
US11577241B2 (en) | 2018-12-03 | 2023-02-14 | Duke University | Acoustofluidic systems including acoustic wave generators for manipulating fluids, droplets, and micro/nano objects within a fluid suspension and related methods |
US10802090B2 (en) * | 2018-12-21 | 2020-10-13 | Industrial Technology Research Institute | Magnetic biosensor and method of detecting biosignal |
WO2020191452A1 (en) * | 2019-03-27 | 2020-10-01 | Monash University | A microparticle and/or nanoparticle separation, filtration and/or enriching device and method |
US11668676B2 (en) | 2019-05-30 | 2023-06-06 | The Regents Of The University Of California | Microfluidic acoustic devices and methods |
US11701658B2 (en) | 2019-08-09 | 2023-07-18 | President And Fellows Of Harvard College | Systems and methods for microfluidic particle selection, encapsulation, and injection using surface acoustic waves |
EP3796212B1 (en) | 2019-09-23 | 2024-06-26 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Device for image-based cell classification, method therefor and use thereof |
KR102427393B1 (en) * | 2020-04-29 | 2022-08-01 | 연세대학교 산학협력단 | Bubble Removal Apparatus using Acoustic Waves and Bubble Removal Method using the Same |
US12090481B2 (en) | 2020-11-03 | 2024-09-17 | Applied Cells Inc. | Microfluidic system including cooling device |
CN112986108A (en) * | 2021-03-21 | 2021-06-18 | 厦门大学 | Flow cell for focusing nano particles based on surface acoustic waves |
US20220371932A1 (en) * | 2021-05-24 | 2022-11-24 | Kohler Co. | Multistage greywater treatment system |
WO2023039607A1 (en) * | 2021-09-13 | 2023-03-16 | University Of Virginia | Acoustic trapping microchannel resonance detection and control |
WO2023129369A1 (en) * | 2021-12-28 | 2023-07-06 | The Trustees Of Indiana University | Acoustic device and method for enhanced sensor detection |
CN115624994A (en) * | 2022-10-27 | 2023-01-20 | 广东工业大学 | Non-contact type particle shaking device and method |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3930000A (en) * | 1971-06-16 | 1975-12-30 | Univ Washington | Silver-zinc allantoinate compositions and method of killing bacteria and fungi therewith |
US5030357A (en) * | 1990-09-11 | 1991-07-09 | Lowe Engineering Company | Oil/grease recovery method and apparatus |
US5888428A (en) * | 1992-10-30 | 1999-03-30 | Great Lakes Chemical Corporation | Methods for generating residual disinfectants during the ozonization of water |
US20020172709A1 (en) * | 2001-03-30 | 2002-11-21 | Brian Nielsen | Medical dressing comprising an antimicrobial silver compound and a method for enhancing wound healing |
US20020195404A1 (en) * | 2001-06-26 | 2002-12-26 | Pickens Stanley R. | Method of operating a chemical feeder |
US20060043011A1 (en) * | 2004-08-26 | 2006-03-02 | King Joseph A | Biocide |
US20060108294A1 (en) * | 2004-11-19 | 2006-05-25 | Ebara Corporation | Sewer system |
US20060175264A1 (en) * | 2005-02-07 | 2006-08-10 | Thomas Ballew | Methods and apparatus for septic tank system chlorination |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5633552A (en) * | 1993-06-04 | 1997-05-27 | The Regents Of The University Of California | Cantilever pressure transducer |
US6537498B1 (en) * | 1995-03-27 | 2003-03-25 | California Institute Of Technology | Colloidal particles used in sensing arrays |
US6168948B1 (en) * | 1995-06-29 | 2001-01-02 | Affymetrix, Inc. | Miniaturized genetic analysis systems and methods |
US6254894B1 (en) * | 1996-04-05 | 2001-07-03 | Zodiac Pool Care, Inc. | Silver self-regulating water purification compositions and methods |
US7955561B2 (en) * | 1998-06-09 | 2011-06-07 | The California Institute Of Technology | Colloidal particles used in sensing array |
US6777245B2 (en) * | 2000-06-09 | 2004-08-17 | Advalytix Ag | Process for manipulation of small quantities of matter |
SE522801C2 (en) * | 2001-03-09 | 2004-03-09 | Erysave Ab | Apparatus for separating suspended particles from an ultrasonic fluid and method for such separation |
US7601267B2 (en) * | 2003-03-06 | 2009-10-13 | Albrecht Haake | Method for positioning small particles in a fluid |
US20080156739A1 (en) * | 2006-12-29 | 2008-07-03 | King Joseph A | Ion enhancement |
US7601287B2 (en) | 2005-02-22 | 2009-10-13 | Raytheon Company | Method and apparatus for preform consistency |
US20090226994A1 (en) * | 2005-07-07 | 2009-09-10 | Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. | Method and Device for Acoustic Manipulation of Particles, Cells and Viruses |
WO2007128045A1 (en) * | 2006-05-02 | 2007-11-15 | Monash University | Microfluidic systems using surface acoustic energy and method of use thereof |
JP2009535203A (en) | 2006-05-02 | 2009-10-01 | モナシュ、ユニバーシティ | Concentration and dispersion of small particles in a small fluid volume using acoustic energy |
IL180414A0 (en) | 2006-12-28 | 2007-12-03 | Traceguard Technologies Ltd | Method and apparatus for trace collection |
US9074983B2 (en) * | 2007-03-23 | 2015-07-07 | Honeywell International Inc. | Deposition of sensing layers for surface acoustic wave chemical sensors based on supra-molecular chemistry |
US7837040B2 (en) * | 2007-04-09 | 2010-11-23 | Los Alamos National Security, Llc | Acoustic concentration of particles in fluid flow |
ATE554859T1 (en) * | 2007-05-24 | 2012-05-15 | Univ California | INTEGRATED FLUIDIC DEVICES WITH MAGNETIC SORTING |
ITTO20070554A1 (en) * | 2007-07-26 | 2009-01-27 | Fond Istituto Italiano Di Tec | DEVICE FOR THE CONTROL OF THE MOTION OF FLUIDS IN MICRO OR NANOCANALS BY SURFACE ACOUSTIC WAVES. |
US8120770B2 (en) * | 2007-09-10 | 2012-02-21 | The Penn State Research Foundation | Three-dimensional (3D) hydrodynamic focusing using a microfluidic device |
US20100304501A1 (en) * | 2007-11-09 | 2010-12-02 | Electronics And Telecommunicaations Research Insti | Bio lab-on-a-chip and method of fabricating and operating the same |
US8266950B2 (en) * | 2007-12-19 | 2012-09-18 | Los Alamos National Security, LLP | Particle analysis in an acoustic cytometer |
-
2009
- 2009-12-01 US US12/592,699 patent/US20100140185A1/en not_active Abandoned
- 2009-12-04 WO PCT/US2009/066795 patent/WO2010065868A2/en active Application Filing
- 2009-12-04 US US12/631,059 patent/US8573060B2/en active Active
-
2015
- 2015-09-28 US US14/868,365 patent/US20160096752A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3930000A (en) * | 1971-06-16 | 1975-12-30 | Univ Washington | Silver-zinc allantoinate compositions and method of killing bacteria and fungi therewith |
US5030357A (en) * | 1990-09-11 | 1991-07-09 | Lowe Engineering Company | Oil/grease recovery method and apparatus |
US5888428A (en) * | 1992-10-30 | 1999-03-30 | Great Lakes Chemical Corporation | Methods for generating residual disinfectants during the ozonization of water |
US20020172709A1 (en) * | 2001-03-30 | 2002-11-21 | Brian Nielsen | Medical dressing comprising an antimicrobial silver compound and a method for enhancing wound healing |
US20020195404A1 (en) * | 2001-06-26 | 2002-12-26 | Pickens Stanley R. | Method of operating a chemical feeder |
US20060043011A1 (en) * | 2004-08-26 | 2006-03-02 | King Joseph A | Biocide |
US20060108294A1 (en) * | 2004-11-19 | 2006-05-25 | Ebara Corporation | Sewer system |
US20060175264A1 (en) * | 2005-02-07 | 2006-08-10 | Thomas Ballew | Methods and apparatus for septic tank system chlorination |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10329179B2 (en) | 2009-09-18 | 2019-06-25 | The Texas A&M University System | Zero valent iron systems and methods for treatment of contaminated wastewater |
US11208338B2 (en) | 2009-09-18 | 2021-12-28 | Evoqua Water Technologies Llc | Selenium removal using aluminum salt at conditioning and reaction stages to activate zero-valent iron (ZVI) in pironox process |
US20110174743A1 (en) * | 2009-09-18 | 2011-07-21 | The Texas A & M University System | Hybrid composites for contaminated fluid treatment |
US10377648B2 (en) | 2009-09-18 | 2019-08-13 | The Texas A&M University System | Selenium removal using aluminum salt at conditioning and reaction stages to activate zero-valent iron (ZVI) in pironox process |
US20130327419A1 (en) * | 2012-02-22 | 2013-12-12 | Applied Silver, Inc. | Antimicrobial device |
US11618696B2 (en) | 2013-08-15 | 2023-04-04 | Applied Silver, Inc. | Antimicrobial batch dilution system |
US10640403B2 (en) | 2013-08-15 | 2020-05-05 | Applied Silver, Inc. | Antimicrobial batch dilution system |
US10774460B2 (en) | 2013-12-06 | 2020-09-15 | Applied Silver, Inc. | Antimicrobial fabric application system |
US10087568B2 (en) | 2013-12-06 | 2018-10-02 | Applied Silver, Inc. | Antimicrobial fabric application system |
US10000881B2 (en) | 2013-12-06 | 2018-06-19 | Applied Silver, Inc. | Method for antimicrobial fabric application |
US9689106B2 (en) | 2013-12-06 | 2017-06-27 | Applied Silver, Inc. | Antimicrobial fabric application system |
US11084742B2 (en) | 2014-12-19 | 2021-08-10 | The Texas A&M University System | Activated hybrid zero-valent iron treatment system and methods for generation and use thereof |
US10351807B2 (en) | 2015-08-21 | 2019-07-16 | Applied Silver, Inc. | Systems and processes for treating textiles with an antimicrobial agent |
US11292993B2 (en) | 2015-08-21 | 2022-04-05 | Applied Silver, Inc. | Systems and processes for treating textiles with an antimicrobial agent |
CN106556561A (en) * | 2016-11-28 | 2017-04-05 | 中国科学院苏州生物医学工程技术研究所 | A kind of fluid particles motion control device |
US10760207B2 (en) | 2017-03-01 | 2020-09-01 | Applied Silver, Inc. | Systems and processes for treating textiles with an antimicrobial agent |
US11053637B2 (en) | 2017-03-01 | 2021-07-06 | Applied Silver, Inc. | Systems and processes for treating textiles with an antimicrobial agent |
CN109433285A (en) * | 2018-12-27 | 2019-03-08 | 苏州纳葛诺斯生物科技有限公司 | Micro-and nano-particles micro-fluidic chip based on surface acoustic wave |
Also Published As
Publication number | Publication date |
---|---|
US20160096752A1 (en) | 2016-04-07 |
WO2010065868A2 (en) | 2010-06-10 |
WO2010065868A3 (en) | 2010-08-19 |
US20100139377A1 (en) | 2010-06-10 |
US8573060B2 (en) | 2013-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20160096752A1 (en) | Wastewater treatment | |
US9187351B2 (en) | Water treatment | |
CA2056379C (en) | Biocidal methods and compositions for recirculating water systems | |
US8211318B2 (en) | Biocides and apparatus | |
US20080156739A1 (en) | Ion enhancement | |
JP5606820B2 (en) | Treatment method for open circulating cooling water system | |
US20100143427A1 (en) | Antimicrobial Surfaces | |
US20080095862A1 (en) | Biocide | |
US20210084894A1 (en) | Ion enhancement | |
US9253986B2 (en) | Wash product comprising a disinfectant mixture of silver ions and non-disinfectant hydantoin | |
US20090272698A1 (en) | Bromate suppression | |
US10123539B2 (en) | Bromate suppression | |
US20140124426A1 (en) | Wastewater treatment | |
EP1373135B1 (en) | Stabilised hypobromous acid solutions | |
US20130302440A1 (en) | Antimicrobial surfaces | |
US20100143430A1 (en) | Antimicrobial agents | |
US9975791B2 (en) | Ion enhancement | |
US20140134267A1 (en) | Ion enhancement | |
AU2004261305B2 (en) | Treatment of chloraminated water | |
IL176814A (en) | Biocide formed from a hypochlorite oxidant and an ammonium salt and method of use thereof for controlling biofilm growth |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |